Pregnancy Generates Sustained Maternal Anergy to Fetal Antigen

This article originally appeared here.
Pregnancy Generates Sustained Maternal Anergy to Fetal Antigen
Pregnancy Generates Sustained Maternal Anergy to Fetal Antigen

(HealthDay News) – Pregnancy generates fetal-specific immune cells that suppress the immune response towards the fetus, which are rapidly re-accumulated in subsequent pregnancies, according to an experimental study published online Sept 26 in Nature.

To establish the antigen specificity and cellular origin of maternal regulatory T cells that accumulate during gestation, Jared H. Rowe, PhD, from the University of Minnesota School of Medicine in Minneapolis, and colleagues impregnated female mice with strains of male mice expressing a surrogate fetal antigen.

The researchers found that maternal FOXP3-positive CD4 cells with fetal specificity selectively accumulated during pregnancy. The fetal-specific regulatory T cells persisted at elevated levels after delivery and remained tolerant to pre-existing fetal antigen. While induced FOXP3 expression and proliferation of pre-existing FOXP3-positive cells were the main contributors to regulatory T cell expansion during the primary pregnancy, proliferation of fetal-specific FOXP3-positive cells from the previous pregnancy was the main contributor to the rapid re-accumulation of regulatory T cells during subsequent pregnancies. In secondary versus primary pregnancies, fetal resorption became more resilient to partial maternal FOXP3-positive cell ablation.

"Together, these findings establish a model whereby pregnancy primes the selective accumulation and activation of maternal regulatory T cells with fetal specificity and extend the role of antigen-experienced regulatory T cells from primary into subsequent pregnancies," Rowe and colleagues conclude.

Abstract
Full Text (subscription or payment may be required)